HIV New Product Introduction Toolkit

The 2020 HIV Market Report provides a detailed look at the complex, ever-changing antiretroviral (ARV) and diagnostic markets in low- and...

WHO published guidelines on the management of advanced HIV disease in 2017, promoting a package of interventions to prevent, identify and...

This memo highlights the patient benefits, cost savings and improved supply security associated with proactively switching eligible 2L...

Introducing the fourth edition of CHAI’s HIV Mid-Year Market Memo, a brief that covers the latest trends in the HIV space in low- and...

The CHAI COST Tool is a model that helps to estimate the financial impact of switching existing second-line (2L) patients to optimized,...

CHAI is pleased to release the 10th issue of our annual HIV Market Report: The state of HIV treatment, testing, and prevention in low-...

CHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...

This Toolkit contains various practical tools and guidance to support countries as they introduce point-of-care (POC) HIV technologies...

This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside...

This presentation provides a broad overview of pediatric LPV/r oral pellets, guidance on administration, and key considerations for...